A robustness-first cross-disease framework supports a candidate shared microbial redox axis and disease-specific metabolic divergence in colorectal cancer, Crohn's disease, and liver cirrhosis. (journals.asm.org)

Authors: Sahu K … Aich P Journal: mSystems Published: 2026-09-14 DOI: https://doi.org/10.1128/msystems.00836-26